Planta Med 2000; 66(1): 88-91
DOI: 10.1055/s-0029-1243120
Letter

© Georg Thieme Verlag Stuttgart · New York

Inhibitory Effects of Lignans and Flavonoids in Saiboku-To, a Herbal Medicine for Bronchial Asthma, on the Release of Leukotrienes from Human Polymorphonuclear Leukocytes

Masato Homma1*, Mana Minami1 , Chizu Taniguchi1 , Kitaro Oka1 , Sonoko Morita2 , Tomoyuki Niitsuma2 , Toru Hayashi2
  • 1Department of Clinical Pharmacology, Tokyo University of Pharmacy & Life Science, Hachioji, Tokyo, Japan
  • 2Department of third Internal Medicine, Tokyo Medical College, Shinjuku-ku, Tokyo, Japan
Further Information

Publication History

Received: March 4, 1999

Accepted: June 5, 1999

Publication Date:
24 November 2009 (online)

Abstract

To identify the anti-allergic components contained in Saiboku-To, a herbal medicine for the treatment of bronchial asthma, we studied the effects of eight phenolic compounds, which have been identified as the major human metabolites of Saiboku-To, and three triterpenoids contained in Saiboku-To on the release of leukotriene (LT) from human polymorphonuclear leukocytes (PMLs) stimulated with Ca2+-ionophore A23187.All phenolic compounds exhibited dose-dependent suppression on release of both LTB4 and LTC4, while triterpenoids did not show any effects, except for glycyrrhetinic acid, which selectively inhibited LTC4-release. The five phenolic compounds, magnolol, dihydroxydihydromagnolol, baicalein, medicarpine and davidigenin, were found to exert a marked inhibition on LTB4- and LTC4- release with IC50 values of 0.7–15.3µM. The results suggest that the phenolic compounds contribute to the anti-allergic effects of Saiboku-To through suppression of LT-release from PMLs.

References

  • 1 Nagano H, Kobayashi S, Nakajima S, Egashira Y. Respiration 1988 7: 76-87 (in Japanese)
  • 2 Toda S, Kimura M, Ohnishi M, Nakanishi K. J Ethnopharmacol 1988 24: 303-309
  • 3 Kobayashi I, Hamasaki Y, Sato R, Zaitu M, Muro E, Yamamoto S, Ichimaru T, Miyazaki S. J Ethnopharmacol 1995 48: 33-41
  • 4 Koda A, Nishiyori T, Nagai H, Matsuura N, Tsuchiya H. Folia Pharmacol Jpn 1982 80: 31-41 (in Japanese)
  • 5 Nishiyori T, Nakatomi I, Matsuura N, Nagai H, Koda A. Jpn J Allergol 1983 32: 317-323
  • 6 Homma M, Oka K, Niitsuma T, Itoh H. Lancet 1993 19: 1595
  • 7 Homma M, Oka K, Kobayashi H, Niitsuma T, Yamamoto S, Itoh H, Takahashi N. J Pharm Pharmacol 1993 45: 844-846
  • 8 Homma M, Oka K, Taniguchi C T, Niitsuma T, Hayashi T. Biomed Chromatogr 1997 11: 125-131
  • 9 Chand N, Sofia R D. J Asthma 1995 32: 227-234
  • 10 Kimura Y, Okuda H, Arichi S. Biochem Biophys Acta 1987 922: 278-286
  • 11 Miller D K, Sadowski S, Han G Q, Joshua H. Prostag Leukotr Essent Fatty Acids 1989 38: 137-143
  • 12 Homma M, Oka K, Yamada T, Niitsuma T, Itoh H, Takahashi N. Anal Biochem 1992 202: 179-187
  • 13 Pradelles P, Antoine C, Lellouche J P, Maclouf J. Methods Enzymol 1990 187: 82-89

Dr. Masato Homma

Department of Clinical Pharmacology, Tokyo University of Pharmacy & Life Science

Horinouchi

Hachioji

Tokyo 192-0392

Japan

Email: masato@ps.toyaku.ac.jp

Fax: +81-426-76-5798

Phone: +81-426-76-5796

    >